Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-21
DOI
10.3389/fphar.2017.00145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells
- (2015) Jun Li et al. AMINO ACIDS
- Chemopreventive effects of aspirin at a glance
- (2015) Muhammad Waqas Usman et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
- (2015) Maria Feldt et al. Journal of Translational Medicine
- Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
- (2015) M. Olivan et al. Biomed Research International
- Type I Collagen Receptor (α2β1) Signaling Promotes Prostate Cancer Invasion through RhoC GTPase
- (2015) Christopher L. Hall et al. NEOPLASIA
- Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
- (2014) Yanqiong Liu et al. BMC Medicine
- Molecular targets of aspirin and cancer prevention
- (2014) L Alfonso et al. BRITISH JOURNAL OF CANCER
- CDK Inhibitors Induce Mitochondria-mediated Apoptosis Through the Activation of Polyamine Catabolic Pathway in LNCaP, DU145 and PC3 Prostate Cancer Cells
- (2014) Elif Arisan et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells
- (2013) Eiji Kashiwagi et al. ENDOCRINE-RELATED CANCER
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Aspirin and cancer risk: a quantitative review to 2011
- (2012) C. Bosetti et al. ANNALS OF ONCOLOGY
- Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis
- (2012) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Arachidonic acid metabolism in human prostate cancer
- (2012) PEIYING YANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The role of aspirin in cancer prevention
- (2012) Michael J. Thun et al. Nature Reviews Clinical Oncology
- Do Hospital Attributes Predict Guideline-Recommended Gastric Cancer Care in the United States?
- (2011) Vikas Dudeja et al. ANNALS OF SURGICAL ONCOLOGY
- DFMO: Targeted risk reduction therapy for colorectal neoplasia
- (2011) Christina M. Laukaitis et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
- (2010) T. M. Brasky et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Suppression of Integrin 3 1 in Breast Cancer Cells Reduces Cyclooxygenase-2 Gene Expression and Inhibits Tumorigenesis, Invasion, and Cross-Talk to Endothelial Cells
- (2010) K. Mitchell et al. CANCER RESEARCH
- Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006
- (2010) Preet K. Dhillon et al. INTERNATIONAL JOURNAL OF CANCER
- Shear-induced Interleukin-6 Synthesis in Chondrocytes
- (2010) Pu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The α2β1 integrin is a metastasis suppressor in mouse models and human cancer
- (2010) Norma E. Ramirez et al. JOURNAL OF CLINICAL INVESTIGATION
- NSAID Inhibition of Prostate Cancer Cell Migration Is Mediated by Nag-1 Induction via the p38 MAPK-p75NTR Pathway
- (2010) S. Wynne et al. MOLECULAR CANCER RESEARCH
- NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
- (2009) Liying Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Polyamines: fundamental characters in chemistry and biology
- (2009) E. Agostinelli et al. AMINO ACIDS
- Reorganization of the integrin α2 subunit controls cell adhesion and cancer cell invasion in prostate cancer
- (2009) Van Slambrouck INTERNATIONAL JOURNAL OF ONCOLOGY
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
- (2009) A Berg et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
- (2008) S. Jain et al. CANCER RESEARCH
- Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
- (2008) Wenyan Lu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Influence of Statin Medications on Prostate-specific Antigen Levels
- (2008) Robert J. Hamilton et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More